Drug Approval | August 05, 2023
USFDA approves Merck’s ERVEBO for use in children 12 months of age and older
Merck continues progress in helping to protect people at risk of Zaire ebolavirus disease
Merck continues progress in helping to protect people at risk of Zaire ebolavirus disease
The company has secured 506 marketing approvals for its oncology products across 76 countries.
Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy
Contracts are related to a $487 million biotech expansion project in Denmark and first phase of a new life sciences production facility valued at $574 million in Central U.S.
The product basket increased to 1800 medicines and 285 Surgical Equipment
More than 9600 Pradhan Mantri Bhartiya Janaushadhi Kendras have been set up covering all districts of the country to promote generic medicines at affordable prices
Tiotropium (as bromide monohydrate) 18 micrograms powder for inhalation in capsule
The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted by AstraZeneca
Health-tech startups have the potential to revolutionize the healthcare sector by supporting innovations
1. 10 crore teleconsultations have been rendered to senior citizens and 5,22,15,224 to women
Subscribe To Our Newsletter & Stay Updated
